North America Clot Management Devices Market Outlook to 2033 Featuring Boston Scientific, Inari Medical, Medtronic, Penumbra, and Teleflex [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
to 2033 - Inferior Vena Cava Filters (IVCF), Embolectomy Balloon Catheters and Others" report has been added to ResearchAndMarkets.com's offering. The "North America Clot Management Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Clot Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Inferior Vena Cava Filters (IVCF), Embolectomy Balloon Catheters and Others The North America Clot Management Devices Market report provides key information and data on : Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033. 2023 company share and distribution share data for Clot Management Devices Market. Global corporate-level profiles of key companies operating within the Clot Management Devices Market. Based on the availability of data for the particular category an
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $238.00 price target on the stock.MarketBeat
- Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in EuropePR Newswire
- FLOWPHYSIX ANNOUNCES STRATEGIC PARTNERSHIP WITH 3COMMA FOR INTERNATIONAL DISTRIBUTION OF INNOVATIVE THROMBECTOMY DEVICE [Yahoo! Finance]Yahoo! Finance
- Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.MarketBeat
- Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $263.00 price target on the stock.MarketBeat
PEN
Earnings
- 7/30/24 - Beat
PEN
Sec Filings
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- 9/4/24 - Form 144
- PEN's page on the SEC website